Vaccine under development in Russia From October to large-scale vaccination New Corona August 4 21:04
Russia has announced that the government will approve the new coronavirus vaccine under development as a vaccine in the middle of this month and will start large-scale vaccination in Japan next October next month. In response to this movement, the media in Europe and the United States have skeptically questioned the safety and efficacy of clinical trial data, saying that the data has not been released.
Dmitriev, President of the Russian Direct Investment Fund, a Russian sovereign wealth fund involved in vaccine development, said in a interview with the state media on March 3 about the vaccine being developed by the National Institute of Epidemiology and Microbiology in Moscow , The government approved the new coronavirus vaccine in the middle of this month, and announced that it will start large-scale vaccination for Russian citizens from October.
On the other hand, Health Minister Murashiko told reporters on the 1st, if the vaccine is completed, he will give priority to medical personnel and teachers who are at high risk of infection and vaccinations.
The vaccine under development in Russia is said to have completed up to the second stage of the three-stage clinical trial, but it is not known whether it has advanced to the final third stage, and the large-scale vaccination will be the final It is expected that it will double as an examination.
Governor Dmitriev said, ``It's a moment like that,'' compared to the fact that the former Soviet Union launched the first artificial satellite of humanity more than 60 years ago, stressing that it will succeed in developing a vaccine earlier than the United States. did.
It seems that Russia has the intention to show off its presence in the international community by appealing that it has developed a new coronavirus vaccine ahead of the rest of the world, but clinical trial data are available from the Western media. Some people have questioned the safety and effectiveness of the system because it has not been published.
WHO "I have not heard the official announcement"
WHO = The World Health Organization has established guidelines for clinical trials to confirm safety and efficacy in humans when developing new vaccines, and regulatory authorities and developers in many countries are based on this guideline. We are conducting clinical trials.
In this, clinical trials need to be conducted in three stages.In the first stage, the vaccine is administered to a small number of healthy adults to confirm the safety and characteristics of the vaccine, and in the second stage to more people. After administration, it will be investigated as to whether or not the required immune response is obtained as well as safety.
And in the third stage, they will carefully check the safety and efficacy of the vaccine for approval.
Although the guideline is not legally binding, each country develops based on this guideline in order to gain international confidence in its safety and effectiveness, and publishes progress and results.
Regarding Russia's move, WHO spokesman Lintmeyer said at a regular press conference at the United Nations Headquarters in Europe that he had "not heard the official announcement yet" and declined to mention it.
On the other hand, in China, the vaccine being developed by the pharmaceutical company "Cancino Biologics" and the PLA institute is in the final stage of the third stage. We have received approval from the military to administer it only internally."